Form 4: Carlyle Group Sells Shares in QuidelOrtho Corp Under 10b5-1 Trading Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between August 7th and August 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of shares of common stock.
• The sales occurred on August 7th and 8th, 2024.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 184,905 shares were sold across multiple transactions at varying prices.
• The weighted average sale prices ranged from $38.9742 to $41.3834 per share.
• Following these transactions, the Carlyle Group's indirect beneficial ownership in QuidelOrtho Corp stands at 8,334,317 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting share sales. It doesn't inherently convey positive or negative sentiment, but rather factual information about transactions.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho Corp's future performance.

Industry Context

Share sales by major holders like Carlyle Group are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The use of a pre-arranged 10b5-1 trading plan suggests the sales were planned in advance to avoid concerns about insider trading.

Stakeholder Impact

• The share sales by Carlyle Group could potentially exert downward pressure on QuidelOrtho Corp's stock price in the short term.
• However, the existence of a pre-arranged trading plan may mitigate concerns about the reasons for the sale.

Key Dates